drugset / Trial / NCT05841043

Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease

NCT05841043

Phase 3 Completed 206 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The study is being conducted to assess the efficacy, safety and tolerability of SHR8028 eye drops in comparison to the vehicle for the treatment of dry eye disease.

Timeline

Start
2021-03-04
Primary completion
2022-04-02
Completion
2022-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.1 % Topical

Indications